News
Tuesday, December 05, 2023
MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt Germany, a leading science and technology company, today launched its AIDDISON™ drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through SynthiaTM retrosynthesis software application programing interface (API) integration. It combines generative AI, machine learning and computer-aided drug-design to speed up drug
